Latest filing published 08 Sept 2026 for TECOGEN INC.. Read the official filing
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Abinand Rangesh in Tecogen Inc. We count 6 filings; the first trade dates from 20 March 2023 and the latest from 26 June 2026.
No open-market sale appears; the market trades are 4 purchases worth €8,017. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. 2026 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €1,031. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -13.3%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 8 September 2026, reports a share grant in Tecogen Inc. The last insider purchase was made public on 23 March 2026, 209 days ago. Typically, a trade is published a median of 7 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations